Free Trial

AssuredPartners Investment Advisors LLC Buys Shares of 4,284 Exponent, Inc. (NASDAQ:EXPO)

Exponent logo with Business Services background

AssuredPartners Investment Advisors LLC acquired a new stake in Exponent, Inc. (NASDAQ:EXPO - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 4,284 shares of the business services provider's stock, valued at approximately $382,000.

Other hedge funds have also recently added to or reduced their stakes in the company. Barclays PLC boosted its position in shares of Exponent by 219.0% in the third quarter. Barclays PLC now owns 96,526 shares of the business services provider's stock worth $11,127,000 after buying an additional 66,263 shares during the period. Allspring Global Investments Holdings LLC grew its holdings in shares of Exponent by 223.4% during the fourth quarter. Allspring Global Investments Holdings LLC now owns 6,158 shares of the business services provider's stock valued at $541,000 after purchasing an additional 4,254 shares during the last quarter. JPMorgan Chase & Co. boosted its holdings in shares of Exponent by 63.6% during the third quarter. JPMorgan Chase & Co. now owns 630,644 shares of the business services provider's stock valued at $72,701,000 after acquiring an additional 245,086 shares during the period. Argent Capital Management LLC increased its holdings in shares of Exponent by 17.3% in the 4th quarter. Argent Capital Management LLC now owns 28,323 shares of the business services provider's stock worth $2,524,000 after acquiring an additional 4,173 shares during the period. Finally, Citigroup Inc. boosted its stake in Exponent by 174.7% during the 3rd quarter. Citigroup Inc. now owns 48,309 shares of the business services provider's stock valued at $5,569,000 after purchasing an additional 30,723 shares during the period. 92.37% of the stock is owned by institutional investors and hedge funds.

Exponent Stock Performance

Shares of NASDAQ:EXPO traded up $2.10 during trading hours on Wednesday, hitting $82.88. The stock had a trading volume of 143,007 shares, compared to its average volume of 232,577. Exponent, Inc. has a 1-year low of $77.30 and a 1-year high of $115.75. The stock's fifty day simple moving average is $86.30 and its 200 day simple moving average is $95.27. The firm has a market capitalization of $4.21 billion, a price-to-earnings ratio of 39.10 and a beta of 0.77.

Exponent (NASDAQ:EXPO - Get Free Report) last posted its quarterly earnings data on Thursday, February 6th. The business services provider reported $0.46 EPS for the quarter, topping analysts' consensus estimates of $0.40 by $0.06. Exponent had a return on equity of 27.27% and a net margin of 19.52%. During the same period in the prior year, the firm posted $0.41 EPS. As a group, research analysts anticipate that Exponent, Inc. will post 1.98 EPS for the current year.

Insider Buying and Selling at Exponent

In other Exponent news, VP Richard Reiss sold 1,736 shares of the business's stock in a transaction dated Wednesday, February 26th. The stock was sold at an average price of $85.93, for a total transaction of $149,174.48. Following the sale, the vice president now owns 1,800 shares in the company, valued at approximately $154,674. The trade was a 49.10 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 2.10% of the stock is owned by corporate insiders.

Exponent Company Profile

(Free Report)

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.

Further Reading

Institutional Ownership by Quarter for Exponent (NASDAQ:EXPO)

Should You Invest $1,000 in Exponent Right Now?

Before you consider Exponent, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exponent wasn't on the list.

While Exponent currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir’s Big Week Reveals a Rare Growth Story in a Shaky Market
Buy the Fear: 3 Down Stocks That Could 10x Your Profits
Congress Bought THESE Stocks as Tariffs Tanked the Market

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines